Some small IPOs are tentatively scheduled for the short holiday week ahead. Space and defense contractor Karman Holdings ...

"Nasdaq CEO Adena Friedman expects IPOs to return with momentum this year ... Rubenstein that an IPO could come "presumably at some stage." Stripe's leadership appears ready to strike.

(RTTNews) - Maze Therapeutics, Inc., (MAZE), a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines, has priced its initial public offering or IPO of 8 ...

Clinical-stage biopharmaceutical company Aardvark Therapeutics (AARD) priced its IPO of ~5.89M shares at $16.00 per share. All of the shares are being offered by Aardvark. The California-based startup ...

SailPoint stock was trading slightly higher to start the first full day of trading for the cybersecurity company.

In addition, the company said it is in the early stages of developing an ... "Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by ...

Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its common stock to the public at $18.00 per share, the company's shares opened ...

SailPoint intends to use its net proceeds from this offering to repay a portion of its term loan, settle outstanding equity awards and equity appreciation rights, pay outstanding fees under the ...

SailPoint said on Tuesday it was targeting a valuation of up to $11.5 billion in its New York flotation, as the cybersecurity ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...